CONTENTS
|
Index no |
Topic Name |
Page Number |
|
1 |
HOST FACTORS IN INFECTION AND IMMUNE RESPONSE |
4 |
|
2 |
INFECTIONS IN POST-SPLENECTOMY PATIENTS |
8 |
|
3 |
ADULT IMMUNIZATION |
11 |
|
4 |
HEALTH ASPECTS OF INTERNATIONAL TRAVEL |
14 |
|
5 |
HEAT STROKE |
18 |
|
6 |
HOSPITAL-ACQUIRED PNEUMONIA (HAP) |
21 |
|
7 |
ATYPICAL PNEUMONIAS |
24 |
|
8 |
VENTILATOR ASSOCIATED PNEUMONIA |
28 |
|
9 |
CAVITARY PNEUMONIA |
32 |
|
10 |
LUNG ABSCESS |
36 |
|
11 |
CELLULITIS AND NECROTIZING FASCIITIS |
40 |
|
12 |
NECROTIZING FASCIITIS |
42 |
|
13 |
OSTEOMYELITIS |
45 |
|
14 |
TRAVELER’S DIARRHEA |
49 |
|
15 |
CLOSTRIDIUM DIFFICILE INFECTION (CDI) |
53 |
|
16 |
CATHETER-ASSOCIATED URINARY TRACT INFECTIONS (CAUTI) |
58 |
|
17 |
RECURRENT URINARY TRACT INFECTION (UTI) |
62 |
|
18 |
ASYMPTOMATIC BACTERIURIA |
66 |
|
19 |
COMPLICATED URINARY TRACT INFECTIONS (UTIS) |
69 |
|
20 |
PYELONEPHRITIS |
74 |
|
21 |
EMPHYSEMATOUS AND XANTHOGRANULOMATOUS PYELONEPHRITIS |
79 |
|
22 |
XANTHOGRANULOMATOUS PYELONEPHRITIS (XGP) |
81 |
|
23 |
GENITAL ULCERS |
83 |
|
24 |
ENCEPHALITIS |
87 |
|
25 |
ACUTE MENINGITIS |
90 |
|
26 |
CHRONIC MENINGITIS |
93 |
|
27 |
BRAIN ABSCESS |
97 |
|
28 |
POST-EXPOSURE PROPHYLAXIS (PEP) |
101 |
|
29 |
POST-TRANSPLANT INFECTIONS |
104 |
|
30 |
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) |
108 |
|
31 |
TETANUS |
112 |
|
32 |
BOTULISM |
115 |
|
33 |
MENINGOCOCCAL MENINGITIS |
118 |
|
34 |
LEGIONELLA INFECTION |
121 |
|
35 |
TYPHOID FEVER |
124 |
|
36 |
TUBERCULOSIS |
128 |
|
37 |
Treatment Regimens and Guidelines for MDR-TB and XDR-TB |
133 |
|
38 |
LATENT TUBERCULOSIS (LATENT TB) |
136 |
|
39 |
LEPROSY |
141 |
|
40 |
LEPRA REACTIONS |
145 |
|
41 |
INTERFERONS |
148 |
|
42 |
INFECTIOUS MONONUCLEOSIS |
151 |
|
43 |
CYTOMEGALOVIRUS (CMV) INFECTIONS |
155 |
|
44 |
HEMORRHAGIC FEVER SYNDROMES |
159 |
|
45 |
SCRUB TYPHUS |
163 |
|
46 |
DENGUE FEVER |
167 |
|
47 |
DENGUE SHOCK SYNDROME (DSS) |
172 |
|
48 |
ANTIMICROBIAL RESISTANCE (AMR) |
176 |
|
49 |
ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP) |
180 |
|
50 |
CHIKUNGUNYA FEVER |
184 |
|
51 |
RISK STRATIFICATION AND MANAGEMENT OF A CASE OF DOG BITE |
188 |
|
52 |
RABIES POST-EXPOSURE PROPHYLAXIS (PEP) |
192 |
|
53 |
HIV |
195 |
|
54 |
NEUROLOGICAL AND CARDIAC MANIFESTATIONS OF HIV |
201 |
|
55 |
PULMONARY AND GASTROINTESTINAL MANIFESTATIONS OF HIV |
204 |
|
56 |
ONCOLOGICAL AND RHEUMATOLOGICAL MANIFESTATIONS OF HIV |
208 |
|
57 |
OPPORTUNISTIC INFECTIONS IN HIV |
211 |
|
58 |
MANAGEMENT OF HIV |
215 |
|
59 |
POST-EXPOSURE PROPHYLAXIS (PEP) FOR HIV |
219 |
|
60 |
HIV Drug Resistance and HIV Vaccination |
222 |
|
61 |
PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV |
225 |
|
62 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
228 |
|
63 |
LEPTOSPIROSIS |
232 |
|
64 |
HERPES SIMPLEX VIRUS (HSV) |
236 |
|
65 |
HERPES ZOSTER |
239 |
|
66 |
FILARIASIS |
243 |
|
67 |
TOXOPLASMOSIS |
246 |
|
68 |
KALA AZAR (VISCERAL LEISHMANIASIS) |
250 |
|
69 |
DERMAL LEISHMANIASIS |
255 |
|
70 |
AMEBIASIS |
259 |
|
71 |
MALARIA |
263 |
|
72 |
PARASITIC INFESTATIONS OF THE CENTRAL NERVOUS SYSTEM (CNS) |
274 |
|
73 |
PNEUMOCYSTIS JIROVECII PNEUMONIA (PJP) |
276 |
|
74 |
MUCORMYCOSIS |
280 |
|
75 |
ASPERGILLOSIS |
284 |
|
76 |
CANDIDIASIS |
289 |
|
77 |
CRYPTOCOCCAL MENINGITIS |
294 |
|
78 |
Assessment and Management of Pustular Rash |
299 |
|
79 |
Avian Influenza A (H5N1) Virus Infection |
301 |
|
80 |
Acute Pharyngitis |
303 |
|
81 |
Anorectal Abscess |
306 |
|
82 |
Acute Diarrhoea |
308 |
|
83 |
Postoperative Fever |
311 |
|
84 |
Acute Bronchitis |
313 |
|
85 |
Animal Bites |
316 |
|
86 |
Aspiration Pneumonia |
319 |
|
87 |
Maculopapular Rash |
322 |
|
88 |
Vesicular-Bullous Rash |
325 |
|
89 |
Acute Aspiration |
328 |
|
90 |
Chancroid |
331 |
|
91 |
Clostridioides difficile-Associated Disease (CDAD) |
334 |
|
92 |
Dermatophyte Infections |
337 |
|
93 |
Chagas Disease |
340 |
|
94 |
Cholera |
343 |
|
95 |
Diphtheria |
345 |
|
96 |
SYPHILIS |
347 |
|
97 |
INFECTIVE ENDOCARDITIS |
352 |
|
98 |
ORAL ANTIBIOTICS IN IE |
366 |